Fig. 1
From: Mutational profiling of micro-dissected pre-malignant lesions from archived specimens
Benchmarking results for sequencing performance. a Experimental design for performance evaluation using a test DNA specimen (* Exome and †Cancer panel). b, c Fraction of targeted bases covered by a minimum of 20 reads (b) and fraction of PCR duplicates (c) observed in whole exome sequencing. d, e Fraction of targeted bases covered by a minimum of 20 reads (d) and fraction of PCR duplicates (e) observed in cancer panel sequencing. All error bars represent standard deviation